［Summary］Notice Regarding the New Medium-Term Management Plan 2029 "1K Project-SPRING Strategy"
Filed with TSE · · 2 pages · English
Summary by 6ix AI
The plan focuses on strengthening profitability, enhancing corporate value, and establishing a medical food business through M&A and proprietary technologies. The company aims to achieve significant financial targets, including substantial net sales and operating profit by the end of the plan. Overall, the strategy emphasizes sustainable growth and the development of new revenue streams while maintaining financial discipline.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Pharma Foods International Co., Ltd. on 6ix
Story so far
Earlier from Pharma Foods International
- Notice Regarding Acquisition of Shares of Marine Pro Foods Co., Ltd. (to Make It a Subsidiary)
- Supplementary Materials of FY26 Q4 Consolidated Financial Results
- 【 Correction of Numerical Data】Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
- Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2026
- [Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP)
Follow Pharma Foods International into a list and get an email when it puts out news.
Follow Pharma Foods International